Angiodynamics (ANGO) Asset Writedowns and Impairment (2010 - 2026)
Angiodynamics (ANGO) posted Asset Writedowns and Impairment of $986000.0 for Q2 2026, up 2494.74% on a QoQ basis from $38000.0 in Q1 2026, and up 1116.49% year-over-year from $81052.5 in Q2 2025.
Angiodynamics (ANGO) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Angiodynamics' Asset Writedowns and Impairment history runs 17 years deep, the most recent figure standing at $986000.0 for Q2 2026.
- Quarterly Asset Writedowns and Impairment rose 1116.49% year-over-year to $986000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $1.3 million (changed N/A YoY) and the FY2026 annual result came in at $1.3 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $986000.0 for Q2 2026 at Angiodynamics, up from $38000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $3.4 million in Q1 2024 and bottomed at -$158.6 million in Q2 2024.
- A 5-year average of -$9.0 million and a median of $38000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
- Peak annual rise in Asset Writedowns and Impairment reached 5864.91% in 2024, while the deepest fall reached 110043.75% in 2024.
- Angiodynamics' Asset Writedowns and Impairment stood at $87000.0 in 2022, then plunged by 824.14% to -$630000.0 in 2023, then surged by 66.51% to -$211000.0 in 2024, then jumped by 245.5% to $307000.0 in 2025, then soared by 221.17% to $986000.0 in 2026.
- Business Quant data shows ANGO's Asset Writedowns and Impairment at $986000.0 in Q2 2026, $38000.0 in Q1 2026, and $307000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 986,000.00 |
| May 31, 2026 | 986,000.00 |
| Feb 28, 2026 | 38,000.00 |
| Feb 28, 2026 | 38,000.00 |
| Nov 30, 2025 | 307,000.00 |
| Nov 30, 2025 | 307,000.00 |
| Aug 31, 2025 | -27,000.00 |
| Aug 31, 2025 | -27,000.00 |
| May 31, 2025 | -97,000.00 |
| May 31, 2025 | -97,000.00 |
| Feb 28, 2025 | 38,000.00 |
| Feb 28, 2025 | 38,000.00 |
| Nov 30, 2024 | -211,000.00 |
| Nov 30, 2024 | -211,000.00 |
| Aug 31, 2024 | 270,000.00 |
| Aug 31, 2024 | 270,000.00 |
| May 31, 2024 | -158.61 Mn |
| May 31, 2024 | -158.61 Mn |
| Feb 29, 2024 | 3.40 Mn |
| Feb 29, 2024 | 3.40 Mn |